Next Generation Sequencing (NGS) Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Next Generation Sequencing (NGS) Market By Product (Consumables, Instruments, Software and Services)  By Application (Clinical Diagnosis, Drug Discovery, Biomarker Discovery and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies) By Workflow (Pre-Sequencing, Sequencing, NGS Data Analysis) By End User (Academic Institutes & Research Centres, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Description

Global Next Generation Sequencing Market:

The global next generation sequencing market is expected to be valued at US$ 2,378.3 million in market and growing at a CAGR of 16.9% over the forecast period by 2026. Improvising cost related to NGS platforms and improving regulatory framework and reimbursement scenario for particular diagnosis tests related to NGS are the key drivers leading the global next generation sequencing market with low cost, high speed, accuracy are main advantages. Lack of skilled professionals, ethical and legal limitations are the resistance. New technology with include machine learning, predictive algorithms, automation of global analytic libraries, data scientists anticipate a multiple opportunity toward the global next generation sequencing market.

 

Increasing Number of People Who Required Individualistic Drug Treatment

It is noticed that the global next generation sequencing market is influenced mainly by the number of people who required individualized drug treatment which is the key factor causing the next generation sequencing market to grow. This trend is estimated to boost the next generation sequencing market over a next era. People are well aware of the facts and benefits pertaining of NGS. There is considerable number of rises in patients who ask the physician for NGS test seeking early detection or prevention of some deadly diseases. Hence there are around 16.1 million of people who currently need the global next generation sequencing market to find a better alternative for their problem.

 

North America dominates the market share in the global next generation sequencing market

North America contributed major revenue followed by Europe and Asia Pacific. North America dominated the market by high investment in R&D due to increase in cancer patients. Key role is played by innovations in genetic disease diagnosis and government bodies, consequently boosting the uptake of next generation sequencing technology. Europe led the market secondly by prominent market players and collaborations. Asia Pacific grow at CAGR of 20.7 %, obtained by simultaneous funding by government and private organization for innovative technology and biotechnology boosting the global next generation sequencing market.

 

Competition Assessment

Key player’s profiles in the global market include:

  • Illumina, Inc.
  • BGI Group
  • PerkinElmer Inc.
  • Macrogen
  • Hamilton Company
  • Lucigen
  • Intrexon Bioinformatics GmbH
  • Partek Incorporated
  • DNASTAR, Inc.
  • DNAnexus
  • Hoffmann-La Roche Ltd.
  • Becton Dickinson and Company
  • Danaher
  • Oxford Nanopore Technologies
  • Agilent Technologies, Inc.

 

Key Developments:

  • Market players have witnessed the strategic collaboration and acquisition to expand product portfolio and strengthen their position in the market to enhance the revenue of the company.
    • In June 2018, Thermo Fisher Scientific (US) offers sequencers that run on its Ion semiconductor technology (the second-largest segment of the technologies market). The company also offers reagents & consumables, software, and services for NGS research.

 

Global Next Generation Sequencing Market Report Description:

Global next generation sequencing market report gives comprehensive outlook on next generation sequencing market across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global next generation sequencing market gives historical, current, and future market sizes on the basis of product type, application, technology, end user, and region. This report studies global next generation sequencing market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global next generation sequencing market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global next generation sequencing market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global next generation sequencing market

 

Key Findings of the Report:

  • Global next generation sequencing market expanding at significant CAGR over 2020 to 2026 owing due to increase in the rate number of people who required individualistic drug treatment
  • Based on region, North America accounted for larger market revenue share in 2019 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global market

.

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Detailed Segmentation

 

By Product

  • Consumables
  • Instruments
  • Software
  • Services

 

By Application

  • Clinical Diagnosis
  • Drug Discovery
  • Biomarker discovery
  • Others

 

Workflow Outlook

  • Pre-Sequencing
  • Sequencing
  • NGS Data Analysis

By Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing
  • Other Sequencing Technologies

By End User

  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other

 

By Geography:

 

North America

  • USA
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA


Location

GEOGRAPHY

PBI Location Map

Competition Assessment

Key player’s profiles in the global next generation sequencing market include:

  • Illumina, Inc.
  • BGI Group
  • PerkinElmer Inc.
  • Macrogen
  • Hamilton Company
  • Lucigen
  • Intrexon Bioinformatics GmbH
  • Partek Incorporated
  • DNASTAR, Inc.
  • DNAnexus
  • Hoffmann-La Roche Ltd.
  • Becton Dickinson and Company
  • Danaher
  • Oxford Nanopore Technologies
  • Agilent Technologies, Inc.

Table of Content
1. Executive Summary
2. Global Next Generation Sequencing (NGS) Market Introduction
2.1. Global Next Generation Sequencing (NGS) Market – Taxonomy
2.2. Global Next Generation Sequencing (NGS) Market –Definitions
2.2.1. Product Type
2.2.2. Technology
2.2.3. Application
2.2.4. Workflow
2.2.5. End User
3. Global Next Generation Sequencing (NGS) Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Next Generation Sequencing (NGS) Market Dynamic Factors – Impact Analysis
3.6. Global Next Generation Sequencing (NGS) Market – Competition Landscape
4. Global Next Generation Sequencing (NGS) Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Next Generation Sequencing (NGS) Market, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.1. Consumables
5.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Software and Services
5.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Next Generation Sequencing (NGS) Market Forecast, By Technology, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1. Sequencing by synthesis
6.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Ion Semiconductor Sequencing
6.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Single-molecule Real-time Sequencing
6.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Nanopore Sequencing
6.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Other Sequencing Technologies
6.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Next Generation Sequencing (NGS) Market Forecast, By Application, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1. Clinical Diagnostics
7.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Drug Discovery
7.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Biomarker Discovery
7.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Next Generation Sequencing (NGS) Market Forecast, By Workflow, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.1. Pre-Sequencing
8.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Sequencing
8.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. NGS Data Analysis
8.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Next Generation Sequencing (NGS) Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026
9.1. Academic Institutes & Research Centres
9.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Biotechnology and Pharmaceutical Companies
9.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Hospitals & Clinics
9.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Others
9.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
10. Global Next Generation Sequencing (NGS) Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.1. North America
10.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Next Generation Sequencing (NGS) Market – Opportunity Analysis Index, By Product Type, Technology, Application, Workflow, End User and Region, 2020 – 2026
11. North America Next Generation Sequencing (NGS) Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
11.1. Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables
11.1.2. Instruments
11.1.3. Software and Services
11.2. Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Sequencing by Synthesis
11.2.2. Ion Semiconductor Sequencing
11.2.3. Single-molecule Real-time Sequencing
11.2.4. Nanopore Sequencing
11.2.5. Other Sequencing Technologies
11.3. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Clinical Diagnosis
11.3.2. Drug Discovery
11.3.3. Biomarker Discovery
11.3.4. Others
11.4. Workflow Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pre-Sequencing
11.4.2. Sequencing
11.4.3. NGS Data Analysis
11.5. End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Academic Institutes & Research Centres
11.5.2. Biotechnology and Pharmaceutical Companies
11.5.3. Hospitals & Clinics
11.5.4. Other End Users
11.6. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Next Generation Sequencing (NGS) Market – Opportunity Analysis Index, By Product Type, Technology, Application, End User and Country, 2020 – 2026
11.8. North America Next Generation Sequencing (NGS) Market Dynamics – Trends
12. Europe Next Generation Sequencing (NGS) Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
12.1. Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables
12.1.2. Instruments
12.1.3. Software and Services
12.2. Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Sequencing by Synthesis
12.2.2. Ion Semiconductor Sequencing
12.2.3. Single-molecule Real-time Sequencing
12.2.4. Nanopore Sequencing, Other Sequencing Technologies
12.3. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Clinical Diagnostics
12.3.2. Drug Discovery
12.3.3. Biomarker Discovery
12.3.4. Others
12.4. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pre-Sequencing
12.4.2. Sequencing
12.4.3. NGS Data Analysis
12.5. End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Academic Institutes & Research Centres
12.5.2. Biotechnology and Pharmaceutical Companies
12.5.3. Hospitals & Clinics
12.5.4. Other End Users
12.6. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Poland
12.6.8. Rest of Europe
12.7. Europe Next Generation Sequencing (NGS) Market – Opportunity Analysis Index, By Product Type, Technology, Application, Workflow, End User and Country, 2020 – 2026
12.8. Europe Next Generation Sequencing (NGS) Market Dynamics – Trends
13. Asia-Pacific Next Generation Sequencing (NGS) Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
13.1. Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Consumables
13.1.2. Instruments
13.1.3. Software and Services
13.2. Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Sequencing by Synthesis
13.2.2. Ion Semiconductor Sequencing
13.2.3. Single-molecule Real-time Sequencing
13.2.4. Nanopore Sequencing
13.2.5. Other Sequencing Technologies
13.3. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Diagnostics
13.3.2. Drug Discovery
13.3.3. Biomarker Discovery
13.3.4. Others
13.4. Workflow Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pre-Sequencing
13.4.2. Sequencing
13.4.3. NGS Data Analysis
13.5. End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Academic Institutes & Research Centres
13.5.2. Biotechnology and Pharmaceutical Companies
13.5.3. Hospitals & Clinics
13.5.4. Other End Users
13.6. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Next Generation Sequencing (NGS) Market – Opportunity Analysis Index, By Product Type, Technology, Application, Workflow, End User and Country, 2020 – 2026
13.8. Asia-Pacific Next Generation Sequencing (NGS) Market Dynamics – Trends
14. Latin America Next Generation Sequencing (NGS) Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
14.1. Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Consumables
14.1.2. Instruments
14.1.3. Software and Services
14.2. Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Sequencing by Synthesis
14.2.2. Ion Semiconductor Sequencing
14.2.3. Single-molecule Real-time Sequencing
14.2.4. Nanopore Sequencing
14.2.5. Other Sequencing Technologies
14.3. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Diagnostics
14.3.2. Drug Discovery
14.3.3. Biomarker Discovery
14.3.4. Others
14.4. Workflow Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pre-Sequencing
14.4.2. Sequencing
14.4.3. NGS Data Analysis
14.5. End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Academic Institutes & Research Centres
14.5.2. Biotechnology and Pharmaceutical Companies
14.5.3. Hospitals & Clinics
14.5.4. Other End Users
14.6. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Rest of Latin America
14.7. Latin America Next Generation Sequencing (NGS) Market – Opportunity Analysis Index, By Product Type, Technology, Application, Workflow, End User and Country, 2020 – 2026
14.8. Latin America Next Generation Sequencing (NGS) Market Dynamics – Trends
15. Middle East and Africa Next Generation Sequencing (NGS) Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
15.1. Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.1. Consumables
15.1.2. Instruments
15.1.3. Software and Services
15.2. Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.2.1. Sequencing by Synthesis
15.2.2. Ion Semiconductor Sequencing
15.2.3. Single-molecule Real-time Sequencing
15.2.4. Nanopore Sequencing
15.2.5. Other Sequencing Technologies
15.3. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Diagnostics
15.3.2. Drug Discovery
15.3.3. Biomarker Discovery
15.3.4. Others
15.4. Workflow Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. Pre-Sequencing
15.4.2. Sequencing
15.4.3. NGS Data Analysis
15.5. End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Academic Institutes & Research Centres
15.5.2. Biotechnology and Pharmaceutical Companies
15.5.3. Hospitals & Clinics
15.5.4. Other End Users
15.6. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. Israel
15.6.3. South Africa
15.6.4. Rest of MEA
15.7. MEA Next Generation Sequencing (NGS) Market – Opportunity Analysis Index, By Product Type, Technology, Application, Workflow, End User and Country, 2020 – 2026
15.8. MEA Next Generation Sequencing (NGS) Market Dynamics – Trends
16. Competition Landscape
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Illumina, Inc.
16.2.2. BGI Group
16.2.3. PerkinElmer Inc.
16.2.4. Macrogen
16.2.5. Hamilton Company
16.2.6. Lucigen
16.2.7. Intrexon Bioinformatics GmbH
16.2.8. Partek Incorporated
16.2.9. DNASTAR, Inc.
16.2.10. DNAnexus
16.2.11. Hoffmann-La Roche Ltd.
16.2.12. Becton Dickinson and Company
16.2.13. Danaher
16.2.14. Oxford Nanopore Technologies
16.2.15. Agilent Technologies, Inc
17. Research Methodology
18. Key Assumptions and Acronyms

Ask An Analyst

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX